According to filings with the U.S. Securities and Exchange Commission, AION Biosystems is raising up to $5,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Samara Barend played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AION Biosystems
AION Biosystems is on a mission to expand remote patient monitoring with value-added technology, discrete design, predictive intelligence, and market leading low cost. We are a company dedicated to dramatically expanding the use and value of Remote Patient Monitoring through a unique product and technology platform. AION Biosystems leaders have decades of experience in healthcare and technology, with an emphasis on sensor-based monitoring and AI. The company’s medical device engineers, quality engineers, scientists and software teams are poised to make AION Biosystems’ devices and AI platform the preferred technology of clinicians, health systems, long-term care facilities and patients, enabling and improving remote patient monitoring for optimal health outcomes.

To learn more about AION Biosystems, visit http://www.aionbiosystems.com/

Contact:
Samara Barend, Chief Executive Officer
917-902-4986

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.